Article
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal…
medRxiv · 2023 · Najumudeen, A. K.; Fey, S. K.; Millet, L. M.; Ford, C. A.; Gilroy, K.; Gunduz, N.; Ridgway, R. A.; Anderson, E.; Strathdee, D.; Clark, W.; Nixon, C.; Morton, J. P.; Campbell, A. D.; Sansom, O. J.
Key facts
| Title | KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo |
|---|---|
| First author | Najumudeen, A. K.; Fey, S. K.; Millet, L. M.; Ford, C. A.; Gilroy, K.; Gunduz, N.; Ridgway, R. A.; Anderson, E.; Strathdee, D.; Clark, W.; Nixon, C.; Morton, J. P.; Campbell, A. D.; Sansom, O. J. |
| Journal | medRxiv |
| Published | Jan 1, 2023 |
| DOI | 10.1101/2023.08.29.555396 |
| Product codes mentioned | MVU, PFF, PFT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1